Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_assertion type Assertion NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_head.
- NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_assertion description "[The difference in histograms from the metastatic and non-metastatic tumour groups was most useful in pinpointing chromosomal imbalances associated with the metastatic phenotype, indicating that the deletions at 3p12-p14, 3p21, 4p15-p16, 6q24-qter, 8p22-p23, 10q21-qter and 21q22, as well as the over-representations at 1q21-q25, 8q, 9q34, 14q12 and 15q12-q15, occurred significantly more often in the metastatic tumour group.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_provenance.
- NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_assertion evidence source_evidence_literature NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_provenance.
- NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_assertion SIO_000772 10638968 NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_provenance.
- NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_assertion wasDerivedFrom befree-20140225 NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_provenance.
- NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_assertion wasGeneratedBy ECO_0000203 NP718658.RAvfXJnQvDxmSiwjEb8ZYQy8N7UZ8sNKR_gWnlD7ioNlY130_provenance.